| P50 | author | Gerard Aragonès | Q42175522 |
| | Carlos Alonso Villaverde | Q42175527 |
| | Javier A Menendez | Q56503568 |
| | Anna Rull | Q41530405 |
| | Jorge Joven | Q41878569 |
| | Raúl Beltrán-Debón | Q42175504 |
| P2093 | author name string | Jordi Camps | |
| | Cristina Oliveras-Ferraros | |
| | Fernando Rodríguez-Sanabria | |
| | Alejandro Vázquez Martín | |
| P2860 | cites work | A new model ELISA, based on two monoclonal antibodies, for quantification of fatty acid synthase | Q44134496 |
| | Low density lipoprotein apolipoprotein B metabolism in treatment-naive HIV patients and patients on antiretroviral therapy. | Q46694442 |
| | Evaluation of a homogeneous assay for high-density lipoprotein cholesterol: limitations in patients with cardiovascular, renal, and hepatic disorders. | Q47980325 |
| | Limitations of the Friedewald formula for estimating low-density lipoprotein cholesterol in alcoholics with liver disease. | Q52380530 |
| | Serum concentrations of extracellular fatty acid synthase in patients with steatohepatitis | Q59450201 |
| | Atherosclerosis in Patients Infected With HIV Is Influenced by a Mutant Monocyte Chemoattractant Protein-1 Allele | Q59540708 |
| | The role of circulating monocyte chemoattractant protein-1 as a marker of hepatic inflammation in patients with chronic liver disease | Q61945529 |
| | Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients | Q73807088 |
| | AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling | Q22241925 |
| | Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins | Q27478188 |
| | Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production | Q27487550 |
| | Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis | Q29615683 |
| | Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? | Q31085526 |
| | Two-site ELISA for the quantitative determination of fatty acid synthase | Q31877198 |
| | HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study | Q33361587 |
| | Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism | Q33830715 |
| | Estrogen receptor-alpha mediates gender differences in atherosclerosis induced by HIV protease inhibitors | Q34335180 |
| | Integration of human immunodeficiency virus type 1 in untreated infection occurs preferentially within genes | Q35023783 |
| | Mechanisms and strategies for insulin resistance in acquired immune deficiency syndrome | Q35207207 |
| | AMPK-mediated inhibition of mTOR kinase is circumvented during immediate-early times of human cytomegalovirus infection | Q35785196 |
| | Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production | Q35914539 |
| | Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells. | Q35971273 |
| | Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis | Q36317218 |
| | Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells. | Q36508454 |
| | Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators? | Q36523601 |
| | Insulin resistance and HIV infection: a review | Q36741551 |
| | AMPK: a key regulator of energy balance in the single cell and the whole organism. | Q37249357 |
| | AMPK: a metabolic gauge regulating whole-body energy homeostasis | Q37314854 |
| | Metabolic disorders and chronic viral disease: the case of HIV and HCV. | Q37338593 |
| | Acute hepatitis C in HIV-positive individuals. | Q37353887 |
| | HIV-associated vascular diseases: structural and functional changes, clinical implications. | Q37364877 |
| | Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases | Q37366361 |
| | Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer | Q37381193 |
| | Hepatitis C, human immunodeficiency virus and metabolic syndrome: interactions | Q37383401 |
| | Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy | Q39603332 |
| | AMPK-sensed cellular energy state regulates the release of extracellular Fatty Acid Synthase | Q39912447 |
| | The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. | Q40426889 |
| | Fatty acid synthase as a tumor marker: its extracellular expression in human breast cancer | Q40500897 |
| | Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells | Q40565118 |
| | Activation of promoters for cellular lipogenic genes by hepatitis B virus large surface protein | Q40831789 |
| P921 | main subject | fatty acid | Q61476 |
| P304 | page(s) | 92 | |
| P577 | publication date | 2010-08-13 | |
| P1433 | published in | BMC Gastroenterology | Q15759922 |
| P1476 | title | Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infection | |
| P478 | volume | 10 | |